Radiomics and Clinical Characters Based Gaussian Naive Bayes (GNB) Model for Preoperative Differentiation of Pulmonary Pure Invasive Mucinous Adenocarcinoma From Mixed Mucinous Adenocarcinoma
Technology in Cancer Research & Treatment · 2024
DOI: 10.1177/15330338241258415 ↗Kurz gefasst
Fachartikel in der Zeitschrift Technology in Cancer Research & Treatment, 2024. Verfasst von Junjie Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Computed Tomography and Magnetic Resonance, Xing Tai People's Hospital, Xing Tai, He Bei, China. Hauptthemen laut MEDLINE: Adenocarcinoma, Mucinous, Bayes Theorem, Lung Neoplasms, Tomography, X-Ray Computed. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Key development plan of Xingtai.
Abstract (Originalsprache)
Objective
To develop and validate predictive models based on clinical parameters, and radiomic features to distinguish pulmonary pure invasive mucinous adenocarcinoma (pIMA) from mixed mucinous adenocarcinoma (mIMA) before surgery.
Method
From January 2017 to December 2022, 193 pIMA and 111 mIMA were retrospectively analyzed at our hospital in this retrospective study. From contrast-enhanced computed tomography, 1037 radiomic features were extracted. The patients were randomly divided into a training group and a test group (n = 213 and 91, respectively) in a 7:3 ratio. The least absolute shrinkage and selection operator algorithm was used to select radiomic features. In this study, 9 machine learning radiomics prediction models were applied. The radiomics score was then calculated based on the best-performing machine learning model adopted. The clinical model was developed using the same machine learning model of radiomics. In the end, a combined model based on clinical factors and radiomics features was developed. The area under the receiver operating characteristic curve (AUC) value and decision curve analysis (DCA) were used to evaluate the clinical usefulness of the prediction model.
Results
The combined model established by the Gaussian Naive Bayes machine learning method exhibited the best performance. The AUC of the combined model, clinical model, and radiomics model were 0.81, 0.80, and 0.68 in the training group and 0.91, 0.80, and 0.81 in the test group, respectively. The Brier scores of the combined model were 0.171 and 0.112. The DCA curve also showed that the combined model was beneficial to clinical settings.
Conclusion
The combined model integration of radiomics features and clinical parameters may have potential value for the preoperative differentiation of pIMA from mIMA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Computed Tomography and Magnetic Resonance, Xing Tai People's Hospital, Xing Tai, He Bei, China.
- Department of Thoracic Surgery, Xing Tai People's Hospital, Xing Tai, He Bei, China.
- Department of Computed Tomography and Magnetic Resonance, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
ORCID-Profile: Ligang Hao
Förderung
- Key development plan of Xingtai
Zitieren
APA
Zhang, J., Hao, L., Xu, Q., & Gao, F. (2024). Radiomics and Clinical Characters Based Gaussian Naive Bayes (GNB) Model for Preoperative Differentiation of Pulmonary Pure Invasive Mucinous Adenocarcinoma From Mixed Mucinous Adenocarcinoma. Technology in Cancer Research & Treatment. https://doi.org/10.1177/15330338241258415
Vancouver
Zhang J, Hao L, Xu Q, Gao F. Radiomics and Clinical Characters Based Gaussian Naive Bayes (GNB) Model for Preoperative Differentiation of Pulmonary Pure Invasive Mucinous Adenocarcinoma From Mixed Mucinous Adenocarcinoma. Technology in Cancer Research & Treatment. 2024. doi:10.1177/15330338241258415
BibTeX
@article{Zhang2024,
author = {Zhang, Junjie and Hao, Ligang and Xu, Qian and Gao, Fengxiao},
title = {Radiomics and Clinical Characters Based Gaussian Naive Bayes (GNB) Model for Preoperative Differentiation of Pulmonary Pure Invasive Mucinous Adenocarcinoma From Mixed Mucinous Adenocarcinoma},
journal = {Technology in Cancer Research & Treatment},
year = {2024},
doi = {10.1177/15330338241258415}
}
EUVIMED